Literature DB >> 17080425

Iontophoretic drug delivery across human nail.

S Narasimha Murthy1, Dora E Wiskirchen, Christopher Paul Bowers.   

Abstract

Topical trans-nail delivery of antifungal drugs is limited by several physicochemical and physiological factors. Use of chemical permeation enhancers has been a common approach for enhancing trans-nail delivery of drugs. The potential of physical permeation enhancement techniques has been found to be higher than the potential of chemical permeation enhancers in transdermal delivery of hydrophilic drugs and macromolecular therapeutic agents. However, application of physical permeation enhancement techniques has not been explored for trans-nail drug delivery. In the current work, iontophoresis was applied across human nail in vitro to assess its efficiency in enhancing drug delivery. Salicylic acid (SA) was used as test diffusant. The influence of pH, ionic strength, and current density was studied. Obviously, increase in current density increased the trans-nail transport flux. It appears that about 50-100 mM ionic strength is required for optimal conduction of electric current across nail. The flux enhancement factor (iontophoretic flux/passive flux) also increased with increase in pH due to increased ionization of SA. This study demonstrates the efficacy of iontophoresis in enhancing the trans-nail delivery of drugs. Copyright (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17080425     DOI: 10.1002/jps.20757

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  20 in total

Review 1.  Transungual permeation: current insights.

Authors:  Ronak S Bhuptani; Ketaki M Deshpande; Vandana B Patravale
Journal:  Drug Deliv Transl Res       Date:  2016-08       Impact factor: 4.617

2.  The low keratin affinity of efinaconazole contributes to its nail penetration and fungicidal activity in topical onychomycosis treatment.

Authors:  Keita Sugiura; Noriaki Sugimoto; Shinya Hosaka; Maria Katafuchi-Nagashima; Yoshio Arakawa; Yoshiyuki Tatsumi; William Jo Siu; Radhakrishnan Pillai
Journal:  Antimicrob Agents Chemother       Date:  2014-04-21       Impact factor: 5.191

3.  Assessment of iontophoretic and passive ungual penetration by laser scanning confocal microscopy.

Authors:  Julie Dutet; M Begoña Delgado-Charro
Journal:  Pharm Res       Date:  2012-08-07       Impact factor: 4.200

Review 4.  Understanding the formidable nail barrier: A review of the nail microstructure, composition and diseases.

Authors:  Sudhir Baswan; Gerald B Kasting; S Kevin Li; Randy Wickett; Brian Adams; Sean Eurich; Ryan Schamper
Journal:  Mycoses       Date:  2017-01-18       Impact factor: 4.377

5.  Effects of organic solvents on the barrier properties of human nail.

Authors:  Kelly A Smith; Jinsong Hao; S Kevin Li
Journal:  J Pharm Sci       Date:  2011-05-23       Impact factor: 3.534

6.  Iontophoretic terbinafine HCL 1.0% delivery across porcine and human nails.

Authors:  Boaz Amichai; Rachel Mosckovitz; Henri Trau; Orit Sholto; Shirly Ben-Yaakov; Michael Royz; David Barak; Boaz Nitzan; Avner Shemer
Journal:  Mycopathologia       Date:  2009-12-13       Impact factor: 2.574

7.  Influence of pH on transungual passive and iontophoretic transport.

Authors:  Kelly A Smith; Jinsong Hao; S Kevin Li
Journal:  J Pharm Sci       Date:  2010-04       Impact factor: 3.534

8.  Mechanistic study of electroosmotic transport across hydrated nail plates: effects of pH and ionic strength.

Authors:  Jinsong Hao; S Kevin Li
Journal:  J Pharm Sci       Date:  2008-12       Impact factor: 3.534

Review 9.  The role of topical antifungal therapy for onychomycosis and the emergence of newer agents.

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2014-07

10.  Effects of ionic strength on passive and iontophoretic transport of cationic permeant across human nail.

Authors:  Kelly A Smith; Jinsong Hao; S Kevin Li
Journal:  Pharm Res       Date:  2009-03-07       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.